Rat dog micro-cap picks... Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks...

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RockyBalboa who wrote (11710)	4/23/2003 10:19:17 AM
From: Bucky Katt	Read Replies (2) of 48461

CRIS has got game, still> CURIS Issued U.S. Patent on Small Molecule Inhibitors of Hedgehog Pathway Wednesday April 23, 7:59 am ET Claims Cover Cur-61414, a Drug Candidate under Development for Basal Cell Carcinoma CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 23, 2003--CURIS, Inc. (NASDAQ:CRIS - News) - The U.S. Patent and Trademark Office yesterday issued Patent 6,552,016 to Curis covering pharmaceutical preparations containing small molecule compounds that selectively inhibit a biological signaling pathway controlled by a protein called Hedgehog. Included among the small molecules covered by this patent is CUR-61414, a compound that is under development by CURIS as a treatment for basal cell carcinoma, the most common form of cancer in the United States. A recent report in The Proceedings of the National Academy of Sciences has shown that CUR-61414 can selectively kill tumor cells while not harming adjacent normal cells in two models of basal cell carcinoma. This selectivity contrasts with more traditional cancer treatments that often kill both cancer cells and normal cells.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next